Polyfunctionality is a hallmark of protective immunity, yet the molecular mechanisms governing polyfunctional T cells are poorly understood. After TCR activation, naïve CD8 + T cells undergo proliferation and differentiation, which lead to effector functions and memory subset development. However only a portion of activated T cells develop into memory CD8 + T cells and with chronic stimulation become terminally differentiated and exhausted CD8 + T cells, as defined by CCR7 -/CD45RA + , and functionally impair effective immune responses [1] . We therefore probed the ability to reverse terminally differentiated antigen-specific cells using pharmacological agents. Stimulating human memory CD8 + T cells with cognate TCR stimulation in the presence of Wnt agonist enhances polyfunctionality and stemness. Both M1-influenza + and CMV + CD8 + T cell responses were reprogrammed and revealed sustained effects from initial Wnt pathway activation in vitro. Future work with cancer antigens and reprogramming of differentiated CD8 + responses could lead to improved in vitro culture conditions for adoptive immunotherapy. 
